EAGLE ASSET MANAGEMENT INC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 364 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.

Quarter-by-quarter ownership
EAGLE ASSET MANAGEMENT INC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$21,972,792
+3.8%
575,204
-2.0%
0.13%
+10.2%
Q2 2023$21,175,723
-30.5%
587,073
-26.5%
0.12%
-33.7%
Q1 2023$30,489,000
-48.3%
798,362
-25.4%
0.18%
-50.8%
Q4 2022$58,988,000
+12.6%
1,069,991
-19.2%
0.36%
+5.8%
Q3 2022$52,391,000
-14.6%
1,325,019
-5.0%
0.34%
-11.2%
Q2 2022$61,368,000
+28.4%
1,394,737
+16.4%
0.38%
+57.1%
Q1 2022$47,780,000
-5.7%
1,198,107
-4.7%
0.24%
+10.4%
Q4 2021$50,663,000
-15.1%
1,256,542
-14.4%
0.22%
-17.5%
Q3 2021$59,681,000
-22.6%
1,467,088
-13.6%
0.27%
-18.7%
Q2 2021$77,085,000
+2.5%
1,697,542
-4.2%
0.33%
-0.6%
Q1 2021$75,185,000
-5.4%
1,772,000
-4.8%
0.33%
-25.7%
Q4 2020$79,469,000
+40.2%
1,860,706
-13.0%
0.45%
+53.4%
Q3 2020$56,697,000
+4.0%
2,138,721
+1.3%
0.29%
-5.8%
Q2 2020$54,502,000
+43.3%
2,110,871
-0.1%
0.31%
+30.8%
Q1 2020$38,027,000
+40.0%
2,113,788
+38.0%
0.24%
+80.9%
Q4 2019$27,164,000
+13.7%
1,532,141
-0.6%
0.13%
+6.5%
Q3 2019$23,894,0001,540,6160.12%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Third Security, LLC 19,305,403$233,209,00010.86%
BB BIOTECH AG 7,379,832$89,148,0003.13%
SENZAR ASSET MANAGEMENT, LLC 550,544$6,650,572,0001.72%
SNYDER CAPITAL MANAGEMENT L P 2,232,114$26,964,0001.69%
Sterling Global Strategies LLC 22,000$266,0000.98%
IRIDIAN ASSET MANAGEMENT LLC/CT 9,290,024$112,223,0000.98%
MSD Partners, L.P. 965,000$11,657,0000.94%
DOHENY ASSET MANAGEMENT /CA 130,950$1,582,0000.81%
Taylor Wealth Management Partners 128,110$1,548,0000.69%
Bellevue Group AG 318,000$3,841,0000.69%
View complete list of HALOZYME THERAPEUTICS INC shareholders